Search research articles
Contact Us
Filters
Showing results (81-90 of 95) with videos related to
Page
of 10
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
January 24, 2009
A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice
Jason A Bubier, Thomas J Sproule, Oded Foreman, et al.
Transplantation
|
March 8, 2011
Coronary artery disease from isolated non-H2-determined incompatibilities in transplanted mouse hearts
Paul S Russell, Catharine M Chase, Joren C Madsen, et al.
Plos One
|
October 5, 2023
Functional analysis of Collagen 17a1: A genetic modifier of junctional epidermolysis bullosa in mice
Thomas J Sproule, Robert Y Wilpan, Benjamin E Low, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 4, 2011
MHC class I family proteins retard systemic lupus erythematosus autoimmunity and B cell lymphomagenesis
Caroline G McPhee, Thomas J Sproule, Dong-Mi Shin, et al.
International Immunology
|
November 2, 2006
Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease
Stefka B Petkova, Shreeram Akilesh, Thomas J Sproule, et al.
Disease Models & Mechanisms
|
June 3, 2020
Diverse dystonin gene mutations cause distinct patterns of <i>Dst</i> isoform deficiency and phenotypic heterogeneity in <i>Dystonia musculorum</i> mice
Nozomu Yoshioka, Yudai Kabata, Momona Kuriyama, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 1, 2013
IL-21 is a double-edged sword in the systemic lupus erythematosus-like disease of BXSB.Yaa mice
Caroline G McPhee, Jason A Bubier, Thomas J Sproule, et al.
Nature Biotechnology
|
January 19, 2010
Enhanced antibody half-life improves in vivo activity
Jonathan Zalevsky, Aaron K Chamberlain, Holly M Horton, et al.
Plos One
|
October 26, 2023
Dystonin modifiers of junctional epidermolysis bullosa and models of epidermolysis bullosa simplex without dystonia musculorum
Thomas J Sproule, Robert Y Wilpan, John J Wilson, et al.
Plos Genetics
|
February 20, 2014
Molecular identification of collagen 17a1 as a major genetic modifier of laminin gamma 2 mutation-induced junctional epidermolysis bullosa in mice
Thomas J Sproule, Jason A Bubier, Fiorella C Grandi, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 95) with videos related to
Sort By:
Page
of 10
Proceedings of the National Academy of Sciences of the United States of America
|
January 24, 2009
A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice
Jason A Bubier, Thomas J Sproule, Oded Foreman, et al.
Transplantation
|
March 8, 2011
Coronary artery disease from isolated non-H2-determined incompatibilities in transplanted mouse hearts
Paul S Russell, Catharine M Chase, Joren C Madsen, et al.
Plos One
|
October 5, 2023
Functional analysis of Collagen 17a1: A genetic modifier of junctional epidermolysis bullosa in mice
Thomas J Sproule, Robert Y Wilpan, Benjamin E Low, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 4, 2011
MHC class I family proteins retard systemic lupus erythematosus autoimmunity and B cell lymphomagenesis
Caroline G McPhee, Thomas J Sproule, Dong-Mi Shin, et al.
International Immunology
|
November 2, 2006
Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease
Stefka B Petkova, Shreeram Akilesh, Thomas J Sproule, et al.
Disease Models & Mechanisms
|
June 3, 2020
Diverse dystonin gene mutations cause distinct patterns of <i>Dst</i> isoform deficiency and phenotypic heterogeneity in <i>Dystonia musculorum</i> mice
Nozomu Yoshioka, Yudai Kabata, Momona Kuriyama, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 1, 2013
IL-21 is a double-edged sword in the systemic lupus erythematosus-like disease of BXSB.Yaa mice
Caroline G McPhee, Jason A Bubier, Thomas J Sproule, et al.
Nature Biotechnology
|
January 19, 2010
Enhanced antibody half-life improves in vivo activity
Jonathan Zalevsky, Aaron K Chamberlain, Holly M Horton, et al.
Plos One
|
October 26, 2023
Dystonin modifiers of junctional epidermolysis bullosa and models of epidermolysis bullosa simplex without dystonia musculorum
Thomas J Sproule, Robert Y Wilpan, John J Wilson, et al.
Plos Genetics
|
February 20, 2014
Molecular identification of collagen 17a1 as a major genetic modifier of laminin gamma 2 mutation-induced junctional epidermolysis bullosa in mice
Thomas J Sproule, Jason A Bubier, Fiorella C Grandi, et al.
Page
of 10